We knew this would not be an easy transition. The key to success was RPM's ability to manage all aspects of the process, adapt to changing requirements, solve problems quickly and keep the process moving.

As Bridge Laboratories, a global leader in pre-clinical drug evaluation studies, prepared to acquire Gene Logic Labs, it realized that there were several technological factors complicating the transaction. The acquisition’s success relied on Bridge’s ability to seamlessly integrate the two companies’ data, technology infrastructures and communication systems, without business interruption, under an extremely aggressive deadline.
To ensure a successful migration, Bridge selected RPM to lead this complex project due to RPM’s excellent reputation and its experience in pharmaceutical development and contract services.
Download the full case study.